Alternatives

Life Sciences

Our Life Sciences team’s domain expertise, deep network, and advisory capabilities position us to identify the next generation of leading therapeutics, tools, and diagnostics companies.
At a Glance
$650
MillionCapital Raised
25
YearsAverage Experience of Investment Committee
6
Investment Themes

Source: Goldman Sachs Asset Management. As December 31, 2024

What Makes Us Different

Sourcing

We operate a robust, multi-channel sourcing engine that leverages Goldman Sachs’ relationships across academic and medical institutions, corporates, venture capital and private equity firms, and company founders and executives.

Capital Formation

We believe that many life sciences companies would benefit from scaling privately, but a funding gap has historically forced these companies to go public too early. By better aligning investment capital with company innovation, we hope to drive better outcomes for companies and, ultimately, patients.

Value Creation

We partner with companies to enhance and accelerate value creation by helping them establish the right business and financial strategies, execute, and achieve strong exits.

Investments
All12

Source: Goldman Sachs Asset Management as of February 14, 2025. Investments were selected to highlight the largest investments made as of February 14, 2025. We believe these selected case studies should be considered as a reflection of our investment process, and references to these particular assets/portfolio companies should not be considered a recommendation of any particular security, investment, or portfolio company.  Any mention of an investment decision is intended only to illustrate our investment strategy and is not indicative of the performance of our strategy as a whole. It should not be assumed that any investment decisions shown will prove to be profitable or any future investment decisions will be profitable or equal the performance of the investments discussed herein. The holdings and/or allocations shown may not represent all of the strategy’s investments. Please contact your Goldman Sachs Asset Management representative to obtain the holdings presented above as well as each holding’s contribution to performance and a complete list of past recommendations. Please see additional disclosures in the appendix.

Our Leadership Team
Our team comprises experienced life sciences investors with deep domain expertise across disciplines.
Advisory Board
Our investment team is complemented by an industry leading Advisory Board comprised of academics, clinicians, scientific experts, and entrepreneurs.
Start the Conversation
Contact Goldman Sachs Asset Management for a detailed discussion of your needs.
card-poster